New two-medicine approach for stubborn H. pylori infection
Part of Digestive system, Infections clinical trials.
This study tests a simpler two-medicine treatment against a four-medicine approach for people whose first H. pylori treatment failed. It aims to see if the simpler option works just as well in clearing the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old
- You have tried at least one standard H. pylori treatment before, but it didn't work
- You currently have H. pylori, confirmed by a test
- You are not allergic to any of the antibiotics used in the study (like amoxicillin, clarithromycin, or metronidazole)
- You have not used certain antibiotics or stomach acid medicines recently (within 30 days for antibiotics, 14 days for acid reducers)
- You have no conditions like lupus, certain stomach problems (e.g., ulcers with bleeding, gastric cancer), or a weakened immune system (HIV/AIDS)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a two-drug combination (keverprazan and amoxicillin) to see if it works better for treating H. pylori, a bacteria that can cause stomach problems. It is for people who have had H. pylori before and need treatment again.
This study tests a new combination of medicines to treat H. pylori, a stomach infection that can cause ulcers. It aims to see if stronger acid suppression helps the antibiotics work better and clear the infection.
This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.
This study tests a new medicine called Keverprazan, which may help get rid of the H. pylori bacteria that causes stomach ulcers and other problems. If you have H. pylori and haven't been treated before, this trial could help you clear the infection with a new approach.
This study tests a three-drug combination (called triple therapy) to get rid of H. pylori, a bacteria that can cause stomach problems like ulcers and inflammation. If you have H. pylori and one of the listed stomach conditions, this treatment might help clear the infection.
This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.
Hear when a new Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.